SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Gallbladder cancer, a highly aggressive disease, often goes undiagnosed until advanced stages due to nonspecific symptoms and lack of routine screening. Risk factors include chronic inflammation, ...